Dr Amani Beshara (Hillel Yaffe Medical Center, Israel) and colleagues evaluated the value of colonoscopy in the assessment of constipation in young women. The multicentre, cross-sectional study identified 377,795 individuals undergoing colonoscopy, 52.6% women and 47.4% men. Cohort 1 included 7,872 women who underwent colonoscopy for constipation and other indications and cohort 2 included 6,852 women who underwent colonoscopy for constipation only.
In cohort 1, 1,017 women were between 18 and 39 years of age. Three-quarters of these young women (74.8%) had a normal colonoscopy. The authors found that 1.2% had ulcerative colitis, that 0.7% had Crohnâs disease, and that 7.4% had polyps of the colon. In young men undergoing colonoscopy for constipation and other indications, it was revealed that these had a higher rate of polyps of the colon (11.3% vs 7.4%; P=0.011).
Analysing the data from the 807 women between 18 and 39 years of age in cohort 2, the investigators reported comparable results: 75.3% had a normal colonoscopy, the ulcerative colitis rate was 0.7%, the Crohnâs disease rate 0.2%, and the polyps of the colon rate 8.1%. âIn cohort 2, the findings in young women were comparable with those in young men,â added Dr Beshara.
âThe diagnostic yield of colonoscopy for isolated constipation in women under 40 years of age thus appears limited,â concluded Dr Beshara.
- Beshara A, et al. Yield of colonoscopy in evaluation young women with constipation. LB15, UEG Week 2024, 12â15 October, Vienna, Austria.
Medical writing support was provided by Robert van den Heuvel.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« Guar gum alleviates IBS-related constipation in randomised-controlled trial Next Article
Tradipitant improves symptoms of motion sickness »
« Guar gum alleviates IBS-related constipation in randomised-controlled trial Next Article
Tradipitant improves symptoms of motion sickness »
Table of Contents: UEGW 2024
Featured articles
Tamuzimod delivers promising long-term data in ulcerative colitis
CULTIVATE: Good signal for etrasimod in Crohnâs disease
Online First
Upadacitinib associated with normalisation of HRQoL in UC
Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA
New insights into perianal fistulising CD pathogenesis may lead to new therapeutics
TL1A inhibitor tulisokibart shows potential in ulcerative colitis
An accelerated treatment approach may save lives in pancreatic walled-off necrosis
Encouraging results for L-carnitine in non-alcoholic fatty liver disease
LOVE-CD: Vedolizumab yields better outcomes in early than in late CD
Tamuzimod delivers promising long-term data in ulcerative colitis
Cendakimab meets primary endpoints in eosinophilic oesophagitis
How useful is colonoscopy for constipation in young women?
Guar gum alleviates IBS-related constipation in randomised-controlled trial
CULTIVATE: Good signal for etrasimod in Crohnâs disease
Meaningful corticosteroid-sparing effect of mirikizumab in UC
Is FMT a viable option to treat primary C. difficile infections?
Extending ustekinumab dosing interval does not influence drug survival in IBD
TACITO: Does FMT improve ICI plus VEGFR TKI therapy in mRCC?
Related Articles
October 29, 2021
Cabozantinib an option for kidney cancer with brain metastases
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com